Regulation of TNF-α secretion by a specific melanocortin-1 receptor peptide agonist

被引:25
|
作者
Ignar, DM
Andrews, JL
Jansen, M
Eilert, MM
Pink, HM
Lin, PY
Sherrill, RG
Szewczyk, JR
Conway, JG
机构
[1] GlaxoSmithKline, Dept Metab Dis, Res Triangle Pk, NC 27709 USA
[2] GlaxoSmithKline, Dept Mol Pharmacol, Res Triangle Pk, NC 27709 USA
[3] GlaxoSmithKline, Dept Med Chem, Res Triangle Pk, NC 27709 USA
关键词
melanocortin; TNF-alpha; alpha-MSH; melanocortin-1;
D O I
10.1016/S0196-9781(03)00127-X
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The lack of specific pharmacological tools has impeded the evaluation of the role of each melanocortin receptor (MCR) subtype in the myriad physiological effects of melanocortins. 154N-5 is an octapeptide (MFRdWFKPV-NH2) that was first identified as an MC1R antagonist in Xenopus melanophores [J. Biol. Chem. 269 (1994) 29846]. In this manuscript, we show that 154N-5 is a specific agonist for human and murine MC1R. The peptide has negligible activity at MC3R and MC4R and is 25-fold less potent and a weak agonist at MC5R. 154N-5 was tested in both a cellular and an animal model of tumor necrosis factor-alpha (TNF-alpha) secretion. The inhibitory efficacy of 154N-5 on TNF-alpha secretion in both models was similar to the nonselective agonist NDP-alpha-melanocyte stimulating hormone (NDP-alphaMSH), thus, we conclude that inhibition of TNF-alpha secretion by melanocortin peptides is mediated by MC1R. 154N-5 is a valuable new tool for the evaluation of specific contribution of MC1R agonism to physiological and pathological processes. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:709 / 716
页数:8
相关论文
共 50 条
  • [31] Melanocortin-1 receptor ( MC1R ): a review for dermatologists
    Guida, Stefania
    Puig, Susana
    DI Resta, Chiara
    Sallustio, Fabio
    Mangano, Eleonora
    Stabile, Giorgio
    Longo, Caterina
    Pellacani, Giovanni
    Guida, Gabriella
    Rongioletti, Franco
    ITALIAN JOURNAL OF DERMATOLOGY AND VENEREOLOGY, 2024, 159 (03) : 285 - 293
  • [32] Homologous regulation of melanocortin-1 receptor (MC1R) expression in melanoma tumor cells in vivo
    Froidevaux, S
    Eberle, AN
    JOURNAL OF RECEPTOR AND SIGNAL TRANSDUCTION RESEARCH, 2002, 22 (1-4): : 111 - 121
  • [33] Regulation of macrophage TNF-α production by prostaglandin E2 receptor subtype specific agonist at mRNA and protein levels
    Akaogi, J
    Yamada, H
    Kuroda, Y
    Nacionales, DC
    Reeves, WH
    Satoh, M
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S60 - S60
  • [34] Characterisation of ACTH peptides in human skin and their activation of the melanocortin-1 receptor
    Wakamatsu, K
    Graham, A
    Cook, D
    Thody, AJ
    PIGMENT CELL RESEARCH, 1997, 10 (05): : 288 - 297
  • [35] A ligand-mimetic model for constitutive activation of the melanocortin-1 receptor
    Lu, DS
    Vage, DI
    Cone, RD
    MOLECULAR ENDOCRINOLOGY, 1998, 12 (04) : 592 - 604
  • [36] A 3-DIMENSIONAL MODEL FOR THE INTERACTION OF MSH WITH THE MELANOCORTIN-1 RECEPTOR
    PRUSIS, P
    FRANDBERG, PA
    MUCENIECE, R
    KALVINSH, I
    WIKBERG, JES
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 210 (01) : 205 - 210
  • [37] The Melanocortin-1 Receptor Gene Polymorphism and Association with Human Skin Cancer
    Beaumont, Kimberley A.
    Liu, Yan Yan
    Sturm, Richard A.
    G PROTEIN-COUPLED RECEPTORS IN HEALTH AND DISEASE, PT A, 2009, 88 : 85 - 153
  • [38] Polymorphisms in the Melanocortin-1 Receptor (Mc1R) Gene in Vitiligo
    Acar, Eylem
    Bozkurt, Gokay
    Gorgulu, Adnan
    BALKAN MEDICAL JOURNAL, 2012, 29 (01) : 26 - 31
  • [39] The agouti-related protein decapeptide (Yc[CRFFNAFC]Y) possesses agonist activity at the murine melanocortin-1 receptor
    Haskell-Luevano, C
    Monck, EK
    Wan, YP
    Schentrup, AM
    PEPTIDES, 2000, 21 (05) : 683 - 689
  • [40] Evidence for expression of melanocortin-1 receptor in human sebocytes in vitro and in situ
    Böhm, M
    Schiller, M
    Ständer, S
    Seltmann, H
    Li, Z
    Brzoska, T
    Metze, D
    Schiöth, HB
    Skottner, A
    Seiffert, K
    Zouboulis, CC
    Luger, TA
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2002, 118 (03) : 533 - 539